Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 4, 2004, Pages 649-653

  García Rodríguez, Luis A ^a   González Pérez, Antonio ^a  

^a CEIFE ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DRUG USE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK REDUCTION;

EID: 2942608983     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.649.13.4     Document Type: Article

References (23)

1. Majeed A, Babb P, Jones J, Quinn M. Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-1998. BJU Int, 2000;85:1058-62.
2. Sjodahl R. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Extent, mode, and dose dependence of anticancer effects. Am J Med, 2001;110(1A):66S-9S.
3. Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst, 2002;94(4):252-66.
4. Madaan S, Abel PD, Chaudhary KS, et al. Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment. BJU Int, 2000;86(6):736-41.
5. Nelson JE, Harris RE. Inverse association of prostate cancer and non-steroidal anti-inflammatory drugs (NSAIDs): results of a case-control study. Oncol Rep, 2000;7(1):169-70.
6. Roberts RO, Jacobson DJ, Girman CJ, Rhodes T, Lieber MM, Jacobsen SJ. A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer. Mayo Clin Proc, 2002;77(3): 219-25.
7. Habel LA, Zhao W, Stanford JL. Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. Cancer Causes & Control, 2002;13(5):427-34.
8. Norrish AE, Jackson RT, McRae CU. Non-steroidal anti-inflammatory drugs and prostate cancer progression. Int J Cancer, 1998;77(4):511-5.
9. Irani J, Ravery V, Pariente JL, et al. Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk. J Urol, 2002;168(5):1985-8.
10. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr. Aspirin use and risk of fatal cancer. Cancer Res, 1993;53(6):1322-7.
11. Leitzmann MF, Stampfer MJ, Ma J, et al. Aspirin use in relation to risk of prostate cancer. Cancer Epidemiol Biomarkers & Prev, 2002;11(10):1108-11.
12. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Aspirin use and chronic diseases: a cohort study of the elderly. Br Med J, 1989;299:1247-50.
13. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology, 1994;5(2):138-46.
14. Langman MJ, Cheng KK, Gilman EA, Lancashire RJ. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in General Practice Research Database. Br Med J, 2000;320(7250):1642-6.
15. Neugut AI, Rosenberg DJ, Ahsan H, et al. Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomarkers & Prev, 1998;7(10):869-73.
16. Sorensen HT, Friis S, Norgard B, et al. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer, 2003;88(11):1687-92.
17. García Rodríguez LA, Pérez Gutthann S. Use of the U.K. General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol, 1998;45:419-26.
18. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerized data resource in the United Kingdom. BMJ, 1991;302:766-68.
19. Ronquist G, García Rodríguez LA, Ruigómez A, et al. Association between captopril, other antihypertensive drugs and risk of prostate cancer. Prostate, 2004;58(1):50-6.
20. González-Pérez A, García Rodríguez LA, Lopez-Ridaura R. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer, 2003;3(1):28.
21. Pincus T, Swearingen C, Cummins P, Callahan LF. Preference for nonsteroidal antiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis. J Rheumatol, 2000;27(4):1020-7.
22. Ulcickas Yood M, Rothman KJ, Johnson ChC, et al. Using prescription claims data for drugs available over-the-counter (OTC) [abstract]. Pharmacoepidemiol Drug Safety, 2000;9:S37.
23. Langman MJS, Weil J, Wainwright P. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet, 1994;343:1075-8.